President Donald Trump has reinforced his commitment to healthcare price transparency with a new executive order. This directive mandates three key federal agencies to expedite the implementation and enforcement of the rules he introduced in 2019. The Departments of the Treasury, Labor, and Health
In a landmark decision that highlights the significance of accessible health information, District Judge John Bates ordered the Food and Drug Administration (FDA) and other federal health agencies to restore webpages previously removed under the Trump administration's executive orders. The affected
The Medicare Advantage (MA) market has been one of the most rapidly growing sectors in the healthcare industry over the past decade. As we navigate through 2025, there are clear signs indicating that this growth is beginning to decelerate. This analysis delves into the recent trends in MA
The future of U.S. biotechnology research faces uncertainty as potential funding cuts from the National Institutes of Health (NIH) are under consideration. The NIH has long been a critical cornerstone for foundational scientific research, facilitating early experimental work in academic
The ongoing legal battle between three leading pharmacy benefit managers (PBMs) — Express Scripts, Caremark, and Optum Rx — and the Federal Trade Commission (FTC) has garnered substantial attention. The core of the dispute revolves around allegations that these PBMs have engaged in anticompetitive
The British Columbia (BC) Government has recently introduced a series of stringent regulations aimed at addressing the province's escalating drug crisis. These measures focus on ensuring the safe consumption of prescribed alternatives, enhancing oversight of pharmacies, and providing comprehensive
